Heteroarylalkanoic acids as integrin receptor antagonists

Details Heteroarylalkanoic acids as integrin receptor antagonists Heteroarylalkanoic acids as integrin receptor antagonists

2005-08-23

2005-08-23

Dentz, Bernard (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S211070, C514S215000, C514S224200, C514S230500, C540S580000, C544S047000, C544S105000, C546S122000

Reexamination Certificate

active

06933304

ABSTRACT:
The present invention relates to a class of compounds represented by the Formula Ior a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively antagonizing the αVβ3and/or the αVβ5integrin without significantly antagonizing the IIb/IIIa or αVβ6integrin.

REFERENCES:
patent: 5700823 (1997-12-01), Hirth et al.
patent: 5773646 (1998-06-01), Chandrakumar
patent: 5849736 (1998-12-01), Wityak
patent: 5852210 (1998-12-01), Chen
patent: WO 92/07468 (1992-05-01), None
patent: WO 94 08577 (1994-04-01), None
patent: WO 97 44333 (1997-11-01), None
patent: WO 99 26945 (1999-06-01), None
patent: WO 99 30709 (1999-06-01), None
patent: WO 99/30713 (1999-06-01), None
patent: WO 00/07544 (2000-02-01), None
patent: WO 00/72801 (2000-12-01), None
patent: WO 01/24797 (2001-04-01), None

Affiliated with

Also associated with

Rating

Heteroarylalkanoic acids as integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroarylalkanoic acids as integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylalkanoic acids as integrin receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3523345